Mar 06, 2023 / 02:10PM GMT
Tyler Martin Van Buren - Cowen and Company, LLC, Research Division - MD & Senior Equity Research Analyst
Okay. Great. Well, let's go ahead and keep going. Good morning, everyone. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen. And for this first far-side chat, it's my pleasure to introduce Stephen Hoge, President of Moderna. Thank you very much for being here Stephen.
Stephen Hoge - Moderna, Inc. - President
Thank you, Tyler. It's exciting.
Questions and Answers:
Tyler Martin Van Buren - Cowen and Company, LLC, Research Division - MD & Senior Equity Research AnalystSo before I get it started, for the audience, if you guys have questions, feel free to raise your hands as well. And we'll plan to dig in most R&D questions (technical difficulty) I wanted to kick it off with the commercial one. On COVID, you guys have talked about $5 billion in deliveries for 2023, maybe around $2 billion in the first half, $3 billion in the second half. Can you just discuss your confidence in that number and
Trustpilot
